Global transfection technologies market is expected to grow in the upcoming years due to rise in incidence of diseases such as cancer and advancements made in the cell -based therapies.
Transfection technology is used in the production of exogenous nucleic acids such as DNA, RNA and oligonucleotide in the body cell. The transfection technology methods are widely used in genomic studies such as in vitro research, cell representation and RNA interference. It has applications in bioproduction of vaccines and protein manufacturing and medical applications such as animal cell treatment. The delivery of nucleic acids to the cell can be done with the help of electroporation and microinjection, however, these methods are harmful for the cell. Thus, transfection process with use of chemical substances is used for maintaining the cell viability.
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID-19 is expected to have significant impact on Global Transfection Technologies Market.
Top Impacting factors:
- Reagent based transfection technology has experienced rise in demand due to cost effectiveness and less complicated methods which are involved during the transfection.
- Increase in prevalence of diseases such as cancer and obesity is rising the demand for transfection technology, rise in research and development activities in the cell- based therapies is increasing the growth of global transfection technologies market.
- Rise in funding for research and development in transfection technology by government and private firms is boosting the growth of transfection technologies market.
- Restrain factors such as high costs related to the transfection technology instruments is lowering the market growth. Hazards related to negative cell reaction is also restraining the growth of transfection technologies market.
New Product Launch / News:
- In December 2018, Polyplus-transfection SA declared the release of PEIpro-GMP, a transfection reagent for medical and industrial lentivirus and adeno-associated disease (AAV) tissue & DNA therapy. This reagent was launched to promote the medical stage and the commercialization stage of manufacturing.
Key benefits of the report:
- This study presents the analytical depiction of the Global Transfection TechnologiesMarket along with the current trends and future estimations to determine the investments.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Global Transfection Technologies Market share.
- The current market is quantitatively analyzed to highlight theGlobal Transfection TechnologiesMarket growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed Global Transfection TechnologiesMarket analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in theGlobal Transfection TechnologiesMarketReport:
- What are the leading market players active inGlobal Transfection TechnologiesMarket?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
- What Segments and region will drive the market growth & why?
Transfection Technologies Market Report Highlights
| Aspects | Details |
 By Transfection method |
|
 By Application |
|
 By Region |
|
 Key Market Players | Roche, Qiagen, Maxcyte, Promega Corporation, Altogen Biosystem, Polyplus Transfection, Mirius Bio, Thermo Fisher Scientific, Sigma Aldrich, Lonza |
Loading Table Of Content...
